Integrating what matters to patients in the care of older adults with cancer
- PMID: 36102769
- DOI: 10.1016/S2666-7568(22)00185-4
Integrating what matters to patients in the care of older adults with cancer
Erratum in
-
Correction to Lancet Healthy Longev 2022; 3: e577-78.Lancet Healthy Longev. 2022 Oct;3(10):e651. doi: 10.1016/S2666-7568(22)00215-X. Lancet Healthy Longev. 2022. PMID: 36202126 No abstract available.
Conflict of interest statement
NMLB wishes to acknowledge the support of the Royal Marsden National Institute for Health and Care Research Biomedical Research Centre for Cancer. NMLB has received travel grants from Exact Sciences, Pfizer, and Lilly; advisory board fees from Abbott, Sanofi, and Pfizer; and speaker fees from Pfizer, Roche, Sanofi, and AbbVie, outside of the submitted work. JH declares no competing interests.
Comment on
-
Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial.Lancet Healthy Longev. 2022 Sep;3(9):e617-e627. doi: 10.1016/S2666-7568(22)00169-6. Epub 2022 Aug 22. Lancet Healthy Longev. 2022. PMID: 36102776 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
